Nov, 7 2021 Britain has become the first country in the world to approve Lagevrio (molnupiravir). The drug is touted as a potential game changer for the management of COVID-19 patients. The Medicines and Healthcare products Regulatory Agency (MHRA), the…
Recent Post
- Loan Licensing in Pharmaceutical Manufacturing: Key Principles, Guidelines, and Regulatory Framework
- Safe Handling of Narcotic and Psychotropic Drugs in a Wholesale Warehouse: A Complete Guide
- Understanding the Requirements for a Validation Master Plan (VMP) as per Regulatory Agencies: USFDA, EU GMP, MHRA, and PIC/S
- Complete Procedure to Meet CDSCO License Mandate of Class C & D Non-Notified Medical Devices
- Complete list of approved FDC